These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 38646883)

  • 41. Therapeutic treatment with an oral prodrug of the remdesivir parental nucleoside is protective against SARS-CoV-2 pathogenesis in mice.
    Schäfer A; Martinez DR; Won JJ; Meganck RM; Moreira FR; Brown AJ; Gully KL; Zweigart MR; Conrad WS; May SR; Dong S; Kalla R; Chun K; Du Pont V; Babusis D; Tang J; Murakami E; Subramanian R; Barrett KT; Bleier BJ; Bannister R; Feng JY; Bilello JP; Cihlar T; Mackman RL; Montgomery SA; Baric RS; Sheahan TP
    Sci Transl Med; 2022 May; 14(643):eabm3410. PubMed ID: 35315683
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The folate antagonist methotrexate diminishes replication of the coronavirus SARS-CoV-2 and enhances the antiviral efficacy of remdesivir in cell culture models.
    Stegmann KM; Dickmanns A; Gerber S; Nikolova V; Klemke L; Manzini V; Schlösser D; Bierwirth C; Freund J; Sitte M; Lugert R; Salinas G; Meister TL; Pfaender S; Görlich D; Wollnik B; Groß U; Dobbelstein M
    Virus Res; 2021 Sep; 302():198469. PubMed ID: 34090962
    [TBL] [Abstract][Full Text] [Related]  

  • 43. SARS-CoV-2 Mac1 is required for IFN antagonism and efficient virus replication in cell culture and in mice.
    Alhammad YM; Parthasarathy S; Ghimire R; Kerr CM; O'Connor JJ; Pfannenstiel JJ; Chanda D; Miller CA; Baumlin N; Salathe M; Unckless RL; Zuñiga S; Enjuanes L; More S; Channappanavar R; Fehr AR
    Proc Natl Acad Sci U S A; 2023 Aug; 120(35):e2302083120. PubMed ID: 37607224
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease.
    Agostini ML; Andres EL; Sims AC; Graham RL; Sheahan TP; Lu X; Smith EC; Case JB; Feng JY; Jordan R; Ray AS; Cihlar T; Siegel D; Mackman RL; Clarke MO; Baric RS; Denison MR
    mBio; 2018 Mar; 9(2):. PubMed ID: 29511076
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Computational Bioprospecting Guggulsterone against ADP Ribose Phosphatase of SARS-CoV-2.
    Kciuk M; Mujwar S; Rani I; Munjal K; Gielecińska A; Kontek R; Shah K
    Molecules; 2022 Nov; 27(23):. PubMed ID: 36500379
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vitro activity of itraconazole against SARS-CoV-2.
    Van Damme E; De Meyer S; Bojkova D; Ciesek S; Cinatl J; De Jonghe S; Jochmans D; Leyssen P; Buyck C; Neyts J; Van Loock M
    J Med Virol; 2021 Jul; 93(7):4454-4460. PubMed ID: 33666253
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Is the ADP ribose site of the Chikungunya virus NSP3 Macro domain a target for antiviral approaches?
    Shimizu JF; Martins DOS; McPhillie MJ; Roberts GC; Zothner C; Merits A; Harris M; Jardim ACG
    Acta Trop; 2020 Jul; 207():105490. PubMed ID: 32333884
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Insights into antiviral mechanisms of remdesivir, lopinavir/ritonavir and chloroquine/hydroxychloroquine affecting the new SARS-CoV-2.
    Uzunova K; Filipova E; Pavlova V; Vekov T
    Biomed Pharmacother; 2020 Nov; 131():110668. PubMed ID: 32861965
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibition of coronavirus infection by a synthetic STING agonist in primary human airway system.
    Zhu Q; Zhang Y; Wang L; Yao X; Wu D; Cheng J; Pan X; Liu H; Yan Z; Gao L
    Antiviral Res; 2021 Mar; 187():105015. PubMed ID: 33444702
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hepatitis C virus drugs that inhibit SARS-CoV-2 papain-like protease synergize with remdesivir to suppress viral replication in cell culture.
    Bafna K; White K; Harish B; Rosales R; Ramelot TA; Acton TB; Moreno E; Kehrer T; Miorin L; Royer CA; García-Sastre A; Krug RM; Montelione GT
    Cell Rep; 2021 May; 35(7):109133. PubMed ID: 33984267
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Current approaches for target-specific drug discovery using natural compounds against SARS-CoV-2 infection.
    Khare P; Sahu U; Pandey SC; Samant M
    Virus Res; 2020 Dec; 290():198169. PubMed ID: 32979476
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Remdesivir: A beacon of hope from Ebola virus disease to COVID-19.
    Nili A; Farbod A; Neishabouri A; Mozafarihashjin M; Tavakolpour S; Mahmoudi H
    Rev Med Virol; 2020 Nov; 30(6):1-13. PubMed ID: 33210457
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hydrolysis of ADP-Ribosylation by Macrodomains.
    Posavec Marjanovic M; Jankevicius G; Ahel I
    Methods Mol Biol; 2018; 1813():215-223. PubMed ID: 30097870
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Beneficial effect of combinational methylprednisolone and remdesivir in hamster model of SARS-CoV-2 infection.
    Ye ZW; Yuan S; Chan JF; Zhang AJ; Yu CY; Ong CP; Yang D; Chan CC; Tang K; Cao J; Poon VK; Chan CC; Cai JP; Chu H; Yuen KY; Jin DY
    Emerg Microbes Infect; 2021 Dec; 10(1):291-304. PubMed ID: 33538646
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Phytochemicals from Selective Plants Have Promising Potential against SARS-CoV-2: Investigation and Corroboration through Molecular Docking, MD Simulations, and Quantum Computations.
    Kousar K; Majeed A; Yasmin F; Hussain W; Rasool N
    Biomed Res Int; 2020; 2020():6237160. PubMed ID: 33102585
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Host ADP-ribosylation and the SARS-CoV-2 macrodomain.
    Hoch NC
    Biochem Soc Trans; 2021 Aug; 49(4):1711-1721. PubMed ID: 34351418
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Discovery of a Selective Allosteric Inhibitor Targeting Macrodomain 2 of Polyadenosine-Diphosphate-Ribose Polymerase 14.
    Schuller M; Riedel K; Gibbs-Seymour I; Uth K; Sieg C; Gehring AP; Ahel I; Bracher F; Kessler BM; Elkins JM; Knapp S
    ACS Chem Biol; 2017 Nov; 12(11):2866-2874. PubMed ID: 28991428
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The SARS-unique domain (SUD) of SARS coronavirus contains two macrodomains that bind G-quadruplexes.
    Tan J; Vonrhein C; Smart OS; Bricogne G; Bollati M; Kusov Y; Hansen G; Mesters JR; Schmidt CL; Hilgenfeld R
    PLoS Pathog; 2009 May; 5(5):e1000428. PubMed ID: 19436709
    [TBL] [Abstract][Full Text] [Related]  

  • 59. ADP-ribose and analogues bound to the deMARylating macrodomain from the bat coronavirus HKU4.
    Hammond RG; Schormann N; McPherson RL; Leung AKL; Deivanayagam CCS; Johnson MA
    Proc Natl Acad Sci U S A; 2021 Jan; 118(2):. PubMed ID: 33397718
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The mechanisms of catalysis and ligand binding for the SARS-CoV-2 NSP3 macrodomain from neutron and x-ray diffraction at room temperature.
    Correy GJ; Kneller DW; Phillips G; Pant S; Russi S; Cohen AE; Meigs G; Holton JM; Gahbauer S; Thompson MC; Ashworth A; Coates L; Kovalevsky A; Meilleur F; Fraser JS
    Sci Adv; 2022 May; 8(21):eabo5083. PubMed ID: 35622909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.